NPI: 1851812069 · PHILADELPHIA, PA 19144 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/28/2017
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 06/28/2017 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 300 | $0.00 |
| 2020 | 4,662 | $416K |
| 2021 | 9,915 | $806K |
| 2022 | 6,563 | $938K |
| 2023 | 5,284 | $810K |
| 2024 | 7,386 | $897K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,957 | 2,280 | $3.87M |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 14 | 13 | $0.00 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 1,079 | 98 | $0.00 |
| A4657 | Syringe, with or without needle, each | 2,948 | 513 | $0.00 |
| 82728 | 84 | 76 | $0.00 | |
| 83550 | 88 | 79 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 1,342 | 347 | $0.00 |
| 85041 | 186 | 147 | $0.00 | |
| 83970 | 111 | 98 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 544 | 298 | $0.00 |
| 83540 | 88 | 79 | $0.00 | |
| 85048 | 185 | 146 | $0.00 | |
| 82108 | 14 | 14 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,470 | 149 | $0.00 |